Board/Management Information • Sep 21, 2015
Board/Management Information
Open in ViewerOpens in native device viewer
As of September 18, Novozymes has purchased an accumulated 4,894,018 shares with a transaction value of DKK 1,554.0 million under the stock buyback program Novozymes announced in Company announcement No. 6, 2015 and initiated February 2, 2015. Under the program. Novozymes will buy back B shares worth up to DKK 2 billion in total during 2015.
The following transactions have been made under the program in accordance with the provisions of European Commission Regulation (EC) No. 2273/2003 of 22 December 2003, also referred to as the Safe Harbour Regulation:
| Number of shares | Average purchase price Transaction value, DKK | ||
|---|---|---|---|
| Accumulated, last announcement | 4,724,118 | 1,504,703,941 | |
| 14 September 2015 | 34.000 | 294.22 | 10,003,471 |
| 15 September 2015 | 33,900 | 291.61 | 9.885.707 |
| 16 September 2015 | 34,000 | 290.29 | 9.869.875 |
| 17 September 2015 | 34,000 | 289.41 | 9,839,809 |
| 18 September 2015 | 34,000 | 285.50 | 9.707.056 |
| Accumulated under the program | 4.894.018 | 1.554.009.859 |
In addition, transactions necessitated by Novozymes' previously established incentive programs have resulted in a net sale by Novozymes of 11,630 B shares in the period from September 14 to September 18, 2015. The share transactions related to the incentive programs were not part of the Safe Harbour stock buyback program.
Following the transactions stated above, Novozymes owns a total of 8,432,865 treasury shares, corresponding to 2.7% of the stock capital. The total number of shares in the company is 313,000,000 including treasury shares.
September 21, 2015 Company announcement No. 45
Contact information [email protected]
Thomas Bomhoff (DK) +45 3077 1226 [email protected]
Klaus Sindahl (DK) +45 5363 0134 [email protected]
Martin Riise (USA) +1 919 649 2565 [email protected]
Novozymes is the world leader in biological solutions. Together with customers, partners and the global community, we improve industrial performance while preserving the planet's resources and helping build better lives. As the world's largest provider of enzyme and microbial technologies, our bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits that we rely on today and in the future. We call it Rethink Tomorrow. www.novozymes.com
Novozymes A/S CVR number: 10 00 71 27
Novozymes A/S Krogshoejvej 36
2880 Bagsvaerd
Phone: +45 4446 0000
Denmark
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.